Research Paper Volume 15, Issue 17 pp 8744—8769
Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer
Figure 1. The expression of CLCN4. (A) Pan-cancer expression level of CLCN4 in TCGA dataset. (B) Pan-cancer expression levels of CLCN4 in TCGA and GTEx datasets. (C) The CLCN4 expression in various tumor cell lines in CCLE database. *p < 0.05; **p < 0.01; ***p < 0.001.